Navigation Links
China RuiTai International Holdings Retains CCG Elite for Investor Relations Services
Date:3/25/2008

TAI'AN, China, March 25 /Xinhua-PRNewswire-FirstCall/ -- China RuiTai International Holdings Co., Ltd. (OTC Bulletin Board: CRUI) (''China RuiTai'' or ''the Company''), a leading producer and distributor of cellulose ether products in the People's Republic of China (''PRC''), today announced that it has retained CCG Elite to design and execute its investor relations campaign.

China RuiTai's primary operations are conducted through TaiAn RuiTai Cellulose Co., Ltd. (''TaiAn''), a company organized under the laws of the PRC and 99% owned by China RuiTai's wholly-owned subsidiary, Pacific Capital Group Co., Ltd. TaiAn commenced operations in 1999 and engages in the sale of deeply processed chemicals with a primary focus on non-ionic cellulose ether products. Cellulose ether is an organic chemical that dissolves in water and other organic solvents; it acts as a thickener and stabilizer in aqueous solutions, as well an additive in various commercial industries and products. Based on research from the Freedonia Group, the worldwide market for cellulose ether products is expected to reach $1.0 billion by 2010.

The Company sells its products under twelve major product lines marketed under the brand name ''RuiTai.'' The Company's products are used in various applications, such as a stabilizer and thickener in latex paint, in mortar dry mix for building materials, to improve the performance of resin in PVC production and as a membrane reagent stabilizer and thickener in pharmaceuticals and in other applications in the food and cosmetics industries. In the first half of 2007 the Company generated revenues of $16.6 million and net income of $2.8 million, up 33% and 65%, respectively from the year ago period. China RuiTai has thirty sales offices throughout China. In 2007 the Company exported approximately 2,400 tons of cellulose ether products to foreign markets in the United States, Europe, India, the Middle East, and South East Asia.

''As a prominent supplier to the cellulose ether market in China and the world, we believe China RuiTai is ideally positioned to take advantage of strong demand for cellulose ether products,'' commented Dianmin Ma, Chief Executive Officer and Chairman of China RuiTai. ''We intend to expand our cellulose ether business by building additional capacity, executing an aggressive acquisition strategy and increasing our distribution network throughout China and internationally. We look forward to working with CCG Elite to increase our visibility with investors and the media.''

''Worldwide demand for cellulose ether products continues to grow due to widespread applications in the personal care, food, construction and oilfield industries,'' commented Crocker Coulson, President of CCG Elite. ''We believe China RuiTai offers an attractive opportunity for investors seeking an established leader with strong prospects for growth in domestic and international markets.''

About CCG Elite

CCG Elite is a global, full-service investor relations firm, headquartered in Los Angeles, Calif., with offices in New York City, Newport Beach, Calif., Dallas, Texas, Hong Kong, Beijing, Shanghai and Tel Aviv. CCG Elite is uniquely positioned to provide outsourced, high-level investor relations solutions to its clients, combined with an in-depth understanding of Asia's corporate culture and economic environment, to convey their story to funds and broker-dealers located in the U.S. For further information, contact CCG Elite directly, or visit the Company's Web site at http://www.ccgelite.com .

About China RuiTai International Holdings Co., Ltd.

China Ruitai International Holdings Co., Ltd. (OTC Bulletin Board: CRUI), through its operating subsidiary, is engaged in the production, sales, and exportation of deeply processed chemicals, with a primary focus on non-ionic cellulose ether products. Cellulose ether is an organic chemical that acts as a thickener and dissolves in water and other organic solvents. The Company is one of the largest non-ionic cellulose ether producers in China delivering products for the pharmaceutical, PVC manufacturing, construction industry, the personal care market and oil field exploration and recovery industries. China RuiTai exports to United States, Europe, India, the Middle East, and South East Asia.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: This press release contains certain "forward-looking statements," as defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors include, but are not limited to the Company's ability to complete product orders, coordinate product design with its customers, ability to expand and grow its distribution channels, political and economic factors in the People's Republic of China, the Company's ability to find attractive acquisition candidates, dependence on a limited number of larger customers and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

For more information, please contact:

CCG Elite Investor Relations

Crocker Coulson, President

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com


'/>"/>
SOURCE China RuiTai International Holdings Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Medical Technologies Receives CE Mark for Two ECLIA Analyzers and 15 Reagents
2. Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China
3. China Nepstar Chain Drugstore Announces Dividend
4. Alsius Corporation Receives Regulatory Approval in China and Mexico
5. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
6. China Nepstar Chain Drugstore Reports 231.5% Increase in Net Income and Record Gross Margin of 48.5% for Fourth Quarter 2007
7. Flagship Global Health and China HealthCare Holdings Form Strategic Alliance
8. Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities
9. China Nepstar Chain Drugstore to Announce Fourth Quarter 2007 Financial Results on March 19
10. Wyeth to Invest $280 Million to Build State-of-the-Art Nutritional Manufacturing Facility in China
11. Smoking is major risk factor for stroke in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... Hayes, ... published a new eBook titled “ 5 Questions to Ask Before Entering the ... on the Genetic Test Evaluation (GTE) team, the book explores the various types ...
(Date:6/20/2017)... ... June 20, 2017 , ... HOUSTON – Brazos Towers at Bayou ... host of new options for today’s modern senior. Brazos Towers at Bayou Manor has ... they love while offering them the services to support that lifestyle both now and ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... in Cincinnati, OH for leading-edge care, whether or not they have a referral. ... the BIOLASE WaterLase® iPlus™ laser, she targets bacteria and damaged tissue without affecting ...
(Date:6/20/2017)... ... June 20, 2017 , ... This year, participants in the ... finding product improvements that could reduce the occurrence of unplanned extubations (UEs). ... breathing or to provide medication. Sometimes, patient movement can cause unplanned extubations which ...
(Date:6/20/2017)... ... June 20, 2017 , ... Total Security Integrated Systems, one ... the partner of choice by Amtrak to fulfill several projects in various Northeast ... long-distance intercity service in the contiguous United States. Security Executives at the company ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... Israel , May 30, 2017 Therapix ... pharmaceutical Company specializing in the development of cannabinoid-based ... present a company overview at three upcoming scientific ... 7th Annual LD Micro Invitational: ... Date:                     ...
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
(Date:5/22/2017)... COTTAGE, N.Y. , May 22, 2017 /PRNewswire/ ... antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of a ... plain English, the results of a clinical study ... one year treatment with Gene-Eden-VIR/Novirin in individuals suffering ... important to note that there are no other ...
Breaking Medicine Technology: